December, 08 2024 |
At the General Meeting of ACTO, the Results of 2024 Were Summarized, and the Board of the Association for 2025 Was Approved
On December 5, 2024, the annual General Meeting of the Association of Clinical Trials Organizations
(ACTO) took place in Moscow.
|
|
The event, held at the Sokolinya Okhota restaurant, brought together representatives of pharmaceutical companies and contract research organizations to review the results of the year and discuss plans for the future.
The Association's Executive Director, Svetlana Zavidova, presented the annual report on activities,
highlighting key legislative initiatives impacting the clinical research sector in Russia.
The participants approved the rate and procedure for paying membership fees for 2025, elected the
Board and appointed the Executive Director of the Association. The updated Board includes:
- Syuzanna Kiabiya (ICON),
- Peter Kosminsky (Janssen),
- Olga Melnik (Novartis),
- Anna Filimonova (Parexel),
- Marina Filippova (PSI),
- Svetlana Zavidova (Executive Director of AOKI) – ex officio.
A presentation by Marina Filippova from PSI, who shared her experience of launching a startup in
Kazakhstan, sparked particular interest among the attendees.
The discussion of current issues in clinical research continued in an informal setting after the official part of the event concluded.
|
|